Skip to main content

Next Steps for Treatment-Resistant Depression: TMS vs. Ketamine vs. ECT

Learn how clinicians evaluate TMS, ketamine, and ECT for treatment-resistant depression, including patient fit, key decision factors, and when to refer early.

Medical editorial oversight: Dr. Siddharth Arora

Book an Appointment
Treatment-Resistant Depression

When Medications Are Not Enough: What Comes Next

When depression does not lift after several antidepressants, it can start to feel like nothing will help. As days get shorter and routines change, mood symptoms may feel heavier, sleep may be off, and energy may be low, even if you are doing everything you can.

At Resova Health, we focus first on careful psychiatric evaluation, diagnosis, and medication management. Most of our visits are through telemedicine, with select in-person services at our Virginia location. We often meet people who have tried several medications and are wondering about next steps like TMS, ketamine, or ECT.

These treatments are not quick fixes. They are advanced options that may help some patients when standard strategies have not provided enough relief. They require thoughtful assessment, safety screening, and close coordination with your current providers. Here, we explain how clinicians think about treatment-resistant depression, how we compare TMS vs ketamine vs ECT, and why having a steady psychiatric team matters when planning what comes next.

What Treatment-Resistant Depression Means in Real Life

Psychiatrists usually use the term treatment-resistant depression when a person has tried multiple antidepressants at reasonable doses and for a long enough time, often alongside therapy, without feeling much better. This is a medical description, not a sign that you did something wrong or did not try hard enough.

When someone comes to us with treatment-resistant depression, we slow down and look closely. A detailed psychiatric evaluation at Resova Health often includes:

  • Clarifying the diagnosis, for example, major depressive disorder, bipolar depression, or another condition  
  • Reviewing medical history, sleep, hormones, and other factors that may affect mood  
  • Screening for anxiety, PTSD, substance use, and personality factors  
  • Going through each past medication trial, including dose, timing, side effects, and what changed  

This step is important before thinking about TMS, ketamine, or ECT. Sometimes we find that the depression is actually bipolar depression, that a thyroid issue has been missed, or that most past medication trials were cut short by side effects or life events.

After this clarification, some people are better served by adjusting medication, adding an augmenting agent, or changing therapy. Others may be good candidates for an evaluation for advanced treatments. Telepsychiatry lets us do thorough, structured interviews and follow-ups, even if someone lives hours away from any procedure center.

Getting the Most Out of Medications and Therapy First

Before we talk about devices or infusions, we usually ask: have we truly used all reasonable medication and psychotherapy tools for this person?

Common next steps we may look at include:

  • Increasing to the highest tolerated dose of a current antidepressant  
  • Switching to a different medication class if past trials were all similar  
  • Adding an augmenting medication, such as a selected atypical antipsychotic or mood stabilizer  
  • Considering thyroid augmentation or other evidence-informed options when appropriate  
  • Tightening up routines, sleep timing, and therapy work around specific triggers  

For many people with treatment-resistant depression, the best path is still medication-based, but in a more structured and coordinated way. That might mean checking whether doses were ever truly at a therapeutic level, reviewing how often doses were missed, or adjusting timing around sleep and meals.

Psychotherapy also matters. We often:

  • Work with your current therapist so treatment plans match  
  • Help you find therapy resources if you are not in counseling yet  
  • Align medication changes with therapy goals, such as exposure work or trauma processing  

A careful, documented trial of optimized pharmacotherapy is usually needed before referral for TMS, ketamine, or ECT. This record is important for your own safety and for insurance reviews, specialty consultations, and hospital teams that may evaluate you later.

TMS, Ketamine, and ECT: How They Compare Clinically

Once medications and therapy have been carefully tried, some patients and clinicians start to talk about advanced treatments. Each option works differently and fits different situations.

In broad clinical terms:

  • TMS is a noninvasive device treatment that uses magnetic pulses on the scalp to target brain areas linked to mood. Sessions are usually frequent over several weeks.  
  • Ketamine and related medications are given in monitored medical settings and may act more quickly for some people, though effects often need maintenance planning.  
  • ECT is a long established procedure done under anesthesia that uses controlled electrical stimulation. It has strong evidence for severe, psychotic, or life-threatening depression.  

Who might fit which option?

  • TMS may suit people with treatment-resistant depression who can attend many visits, do not have certain seizure risks or unsafe metal in or near the head, and can manage transportation.  
  • Ketamine-based treatments may be considered for patients who have not responded to standard medications and who can be safely monitored during and after each session.  
  • ECT may be recommended when depression is very severe or urgent, such as with high suicidal risk, catatonia, or psychotic symptoms, when potential benefits may outweigh procedural risks.  

At Resova Health, we do not see these options as interchangeable. Our physicians weigh:

  • Exact diagnosis and symptom pattern  
  • Severity and urgency, including safety risks  
  • Past responses to medications and any prior neuromodulation  
  • Medical history and anesthesia risks  
  • Preferences, values, work schedule, and support system  
  • Ability to travel, especially because TMS and ketamine infusions are in-person  

In-person TMS and ketamine infusion therapy are available only at our Virginia location. For many patients, we serve as evaluators and coordinators, working alongside external centers that provide TMS, ketamine, or ECT when that is the right step.

How Psychiatrists Decide What to Recommend and When to Refer

Once we agree that depression is treatment-resistant, the next question is timing. Do we keep refining medications, or is it time to consider a procedure?

Our decision-making framework often includes:

  • Current safety, including suicidal thoughts or self-harm  
  • How much daily life is limited, such as work, school, or parenting  
  • Whether there are psychotic symptoms or catatonia  
  • Medical conditions that may affect anesthesia or seizure threshold  
  • Any prior experience with TMS, ketamine, ECT, or similar treatments  

Generally, we might:

  • Continue focusing on medication and therapy when symptoms are serious but stable, and there are still reasonable medication options left  
  • Suggest evaluation for TMS or ketamine when several medication strategies have failed, impairment is high, and the person can safely participate in outpatient care  
  • Recommend urgent ECT evaluation in a hospital or specialty center when there is severe, life-threatening, or psychotic depression  

Resova Health often acts as a gatekeeper and coordinator. That can include:

  • Independent psychiatric evaluations focused on eligibility and safety  
  • Clear education about potential benefits, risks, and alternatives  
  • Written documentation for referring clinicians and procedure centers  
  • Coordination of care during the treatment course  
  • Resuming longitudinal medication management after TMS, ketamine, or ECT is completed  

Keeping evaluation, procedure delivery, and long-term care in clearly defined roles helps protect clinical integrity, especially for pre-surgical psychological evaluations and other referral-based assessments.

Moving Forward with Careful Support, Not Despair

Treatment-resistant depression can feel isolating, but needing advanced options does not mean you are out of choices. TMS, ketamine, and ECT are better viewed as parts of a broader, carefully managed plan rather than last-ditch efforts.

When patients or referring clinicians connect with Resova Health, they can expect a structured telepsychiatric evaluation, a close review of prior records and treatments, and a careful clarification of diagnosis and safety needs. The outcome is usually a clear, individualized plan that may include medication adjustments, psychotherapy coordination, and, when clinically appropriate, thoughtful referral for advanced treatments with follow-up care over time.

Results with any option vary, and no single treatment fits everyone. What we can offer is a steady, physician-led, psychiatry-first approach that stays with you through each step, through seasonal changes, and through the slow, real work of building a more stable mood over time.

Take The Next Step Toward Relief From Depression

If you are struggling with treatment-resistant depression, you do not have to face it alone. At Resova Health, we take the time to understand your unique history and tailor a plan that fits your needs. We are here to answer your questions, discuss your options, and help you decide what feels right for you. To schedule an appointment or ask about next steps, please contact us today.

Accepted Insurance & Partners

Aetna
BlueCross BlueShield
Cigna
Humana
United Healthcare
Tricare
Oxford Health Plans
Oscar
New Directions
Molina
Get started today

Ready when you are. Let's get you feeling better.

Our board-certified providers are here to help you get the care you deserve.